HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Wenxian Sun Selected Research

Wenxian Sun Research Topics

Disease

11Infections
01/2022 - 03/2006
2Ischemic Stroke
01/2022 - 01/2020
2Stroke (Strokes)
01/2021 - 01/2020
2Disease Progression
01/2019 - 08/2015
1Mycoses (Diseases, Fungus)
01/2022
1Atrophy
01/2021
1Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2021
1Obesity
01/2021
1Inflammation (Inflammations)
01/2020
1Necrosis
01/2019
1Porcine Reproductive and Respiratory Syndrome (PRRS)
12/2018
1Cysts
01/2017
1Bacterial Infections (Bacterial Infection)
07/2015
1Hematologic Neoplasms (Hematological Malignancy)
02/2011
1Neoplasms (Cancer)
02/2011
1Leukemia
02/2011
1Multiple Myeloma
02/2011
1Weight Loss (Weight Reduction)
02/2011

Drug/Important Bio-Agent (IBA)

7Proteins (Proteins, Gene)FDA Link
01/2020 - 05/2014
2Pattern Recognition ReceptorsIBA
12/2018 - 07/2015
2FlagellinIBA
07/2015 - 03/2006
1Virulence Factors (Pathogenicity Factors)IBA
01/2022
1Tyrosine (L-Tyrosine)FDA Link
01/2022
1LipidsIBA
01/2022
1Phosphoric Monoester Hydrolases (Phosphatases)IBA
01/2022
1HDL CholesterolIBA
01/2022
1MycotoxinsIBA
01/2021
1NLR ProteinsIBA
01/2021
1Alanine (L-Alanine)FDA Link
01/2021
1Aspartate Aminotransferases (Aspartate Transaminase)IBA
01/2021
1jasmonic acid (jasmonate)IBA
01/2021
1Galectin 3 (LGALS3)IBA
01/2021
1Hemoglobins (Hemoglobin)IBA
01/2020
1AlbuminsIBA
01/2020
1Indicators and Reagents (Reagents)IBA
01/2020
1Type III Secretion SystemsIBA
01/2019
1Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
12/2018
1Phosphotransferases (Kinase)IBA
12/2018
1Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric
01/2017
1loricrinIBA
01/2017
1RNA (Ribonucleic Acid)IBA
11/2015
1Mitogen-Activated Protein KinasesIBA
08/2015
1Peptide Elongation Factor Tu (EF-Tu)IBA
07/2015
1Polysaccharides (Glycans)IBA
05/2014
18- ethoxy- 2- (4- fluorophenyl)- 3- nitro- 2H- chromeneIBA
02/2011
1Cyclin D2IBA
02/2011
1CyclinsIBA
02/2011
1Phosphatidylinositols (Phosphatidylinositol)IBA
02/2011
18- (4- carboxymethyloxy)phenyl- 1,3- dipropylxanthineIBA
03/2006

Therapy/Procedure

1Therapeutics
02/2011